Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of aGVHD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02631759
What this trial is testing

Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage

Who this might be right for
Acute intraCerebral Haemorrhage
Hospices Civils de Lyon 50
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT05936281
What this trial is testing

The Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)

Who this might be right for
GoutGout Initiating Urate-loweringUrate-lowering Therapy
Changchun GeneScience Pharmaceutical Co., Ltd. 165
Post-approval studies (Phase 4)WithdrawnNCT02144831
What this trial is testing

The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack

Who this might be right for
Transient Ischemic AttacksMinor Stroke
University of Alberta
Large-scale testing (Phase 3)UnknownNCT04597775
What this trial is testing

Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis

Who this might be right for
SARS-CoV Infection
Regional Center for Disease Control and Prevention, Jordan 93
Post-approval studies (Phase 4)Study completedNCT00362544
What this trial is testing

PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute Leukaemia

Who this might be right for
Leukemia
Gilead Sciences 30
Not applicableStudy completedNCT00321009
What this trial is testing

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

Who this might be right for
Coronary Artery DiseaseAcute Myocardial Infarction
Corewell Health East 60
Testing effectiveness (Phase 2)Looking for participantsNCT06839456
What this trial is testing

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Who this might be right for
LeukemiaHigh Risk Acute Lymphoblastic LeukemiaHigh Risk Acute Myeloid Leukemia+11 more
Children's Hospital of Philadelphia 100
Large-scale testing (Phase 3)Ended earlyNCT02770729
What this trial is testing

Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.

Who this might be right for
Endophthalmitis
University of Campinas, Brazil 3,640
Not applicableUnknownNCT03621111
What this trial is testing

A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction

Who this might be right for
Myocardial Infarction, AcuteST Segment Elevation Myocardial InfarctionNon-ST Elevation Myocardial Infarction (nSTEMI)
Azienda ULSS 5 Polesana 120
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableWithdrawnNCT04993664
What this trial is testing

Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)

Who this might be right for
Acute Coronary SyndromeLipoproteinemiaInflammation+1 more
University Medical Centre Ljubljana
Not applicableStudy completedNCT02106234
What this trial is testing

A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?

Who this might be right for
Contrast Induced NephropathyAcute Kidney Injury
Maastricht University Medical Center 660
Testing effectiveness (Phase 2)Ended earlyNCT04435808
What this trial is testing

Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

Who this might be right for
COVID-19
University of New Mexico 1
Large-scale testing (Phase 3)Study completedNCT05381428
What this trial is testing

Prophylaxis of Post-ERCP Acute Pancreatitis

Who this might be right for
Pancreatitis, Acute
Azienda USL Reggio Emilia - IRCCS 184
Large-scale testing (Phase 3)Ended earlyNCT03469050
What this trial is testing

Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.

Who this might be right for
Diverticulitis
Alfasigma S.p.A. 193
Testing effectiveness (Phase 2)Study completedNCT00189748
What this trial is testing

Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Who this might be right for
Bone Marrow TransplantationGraft Versus Host DiseaseGraft-Versus-Host Disease+1 more
Astellas Pharma Inc
Post-approval studies (Phase 4)UnknownNCT05634915
What this trial is testing

Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantationAcute Leukemia
The First Affiliated Hospital of Soochow University 90
Testing effectiveness (Phase 2)Study completedNCT01334086
What this trial is testing

Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
University Health Network, Toronto 41
Large-scale testing (Phase 3)Study completedNCT01005888
What this trial is testing

C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
Shire 26
Next Page